PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of procrsmedFormerly medchtJournal of the Royal Society of MedicineProceedings of the Royal Society of Medicine
 
Proc R Soc Med. 1975 June; 68(6): 386–387.
PMCID: PMC1863750

Early detection of metastatic breast cancer using new bone scanning agents.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (352K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
 
 

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Charkes ND, Young I, Sklaroff DM. The pathologic basis of the strontium bone scan. Studies following administration of strontium chloride Sr 85 and strontium nitrate Sr 85. JAMA. 1968 Dec 9;206(11):2482–2488. [PubMed]
  • Citrin DL, Bessent RG, Tuohy JB, elms ST, McGinlay E, Greig WR, Blumgart L. A comparison of phosphate bone-scanning agents in normal subjects and patients with malignant disease. Br J Radiol. 1975 Feb;48(566):118–121. [PubMed]
  • Citrin DL, Bessent RG, Tuohy JB, Greig WR, Blumgart LH. Quantitative bone scanning: a method for assessing response of bone metastases to treatment. Lancet. 1974 Jun 8;1(7867):1132–1133. [PubMed]
  • Galasko CS, Doyle FH. The response to therapy of skeletal metastases from mammary cancer. Assessment by scintigraphy. Br J Surg. 1972 Feb;59(2):85–88. [PubMed]
  • Galasko CS, Westerman B, Sellwood RA, Burn JI. Use of the gamma camera for early detection of osseous metastases from mammary cancer. Br J Surg. 1968 Aug;55(8):613–615. [PubMed]

Articles from Proceedings of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press